Vitiligo-like lesions associated with ribociclib in a woman with metastatic breast cancer.

Alper Türkel Cengiz Karaçinİrem ÖnerErdoğan ŞeyranBerna Öksüzoğlu

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Vitiligo-like lesions are not a life-threatening side effect. However, it significantly affects the quality of life and disrupts the patient's compliance with treatment. Cyclin-dependent kinase 4/6 inhibitors can inhibit cell division or cause premature cell death by acting on the melanocyte cell cycle.

Keyphrases

cell cycle
metastatic breast cancer
cell death
cell proliferation
case report
single cell
cell therapy
cell cycle arrest
stem cells